Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)

NCT ID: NCT07167225

Last Updated: 2025-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-03

Study Completion Date

2028-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the amount of nicotine, cannabis, and toxicants linked to the use of nicotine e-cigarette and/or cannabis products in the blood and urine of young adult users as well as the cannabis and nicotine use behaviors of consumers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVE:

I. To evaluate differences in self-reported nicotine and cannabis use behaviors and biomarkers of exposure to toxicants and carcinogens by product use status, to generate effect sizes required to calculate sample sizes needed for a larger study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cigarette Smoking-Related Carcinoma E-Cig Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

E-cigarette consumers

Predominant e-cigarette consumers

Effectiveness of different recruitment approaches

Intervention Type OTHER

Subjects will asked which type of recruitment material they've seen when completing the screening survey

Choice of study completion locations

Intervention Type OTHER

subjects will choose location when coordinator calls to schedule appointment

E-cigarette dependence Scale

Intervention Type OTHER

A 22-item questionnaire measuring e-cigarette dependence. Higher scores indicate greater dependence.

Cannabis consumers

Predominant cannabis consumers

Effectiveness of different recruitment approaches

Intervention Type OTHER

Subjects will asked which type of recruitment material they've seen when completing the screening survey

Choice of study completion locations

Intervention Type OTHER

subjects will choose location when coordinator calls to schedule appointment

Cannabis Engagement Assessment

Intervention Type OTHER

Self reported measure of current cannabis use that contains 30 questions assessing quantity, frequency of use and method of consumption in the past 30 days.

e-cigarette -cannabis coconsumers

Consumers who use both e-cigarettes and cannabis .

Effectiveness of different recruitment approaches

Intervention Type OTHER

Subjects will asked which type of recruitment material they've seen when completing the screening survey

Choice of study completion locations

Intervention Type OTHER

subjects will choose location when coordinator calls to schedule appointment

Cannabis Engagement Assessment

Intervention Type OTHER

Self reported measure of current cannabis use that contains 30 questions assessing quantity, frequency of use and method of consumption in the past 30 days.

E-cigarette dependence Scale

Intervention Type OTHER

A 22-item questionnaire measuring e-cigarette dependence. Higher scores indicate greater dependence.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Effectiveness of different recruitment approaches

Subjects will asked which type of recruitment material they've seen when completing the screening survey

Intervention Type OTHER

Choice of study completion locations

subjects will choose location when coordinator calls to schedule appointment

Intervention Type OTHER

Cannabis Engagement Assessment

Self reported measure of current cannabis use that contains 30 questions assessing quantity, frequency of use and method of consumption in the past 30 days.

Intervention Type OTHER

E-cigarette dependence Scale

A 22-item questionnaire measuring e-cigarette dependence. Higher scores indicate greater dependence.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Young adult (18-25 years old).
* Ability to read and write in English.
* Participants must fall into one of the following groups (based on self-report):
* Predominant e-cigarette consumer: defined as using nicotine-containing e-cigarettes daily for the past six months but not having used other nicotine containing products more than weekly or cannabis products for the past month.
* Predominant cannabis consumer: defined as using cannabis at least 3x/week for the past six months in any form, including smoking, vaping, and oral use, with no more than weekly use of any nicotine or tobacco products.
* E-cigarette-cannabis co-consumers: defined as daily use of nicotine e-cigarettes and use of cannabis at least 3x/week, including smoking, vaping, and oral use, for at least the past six months, with no use of other nicotine containing products more than weekly.
* No self-reported diagnosis of kidney disease (current, or within the past year prior to the study visit).
* Participants must understand the voluntary nature of this study and sign a written informed consent form before proceeding with study activities.

Exclusion Criteria

* Individuals under the age of 18 or over the age of 25.
* Currently pregnant or breastfeeding (female participants).
* Unwilling or unable to follow protocol requirements
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Roswell Park Cancer Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Danielle Smith, PhD

Role: PRINCIPAL_INVESTIGATOR

Roswell Park

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Roswell Park Comprehensive Cancer Center

Buffalo, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

ASK RPCI

Role: CONTACT

1-800-767-9355

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

ASK RPCI

Role: primary

877-275-7724

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

I-4235024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cannabis and Tobacco Co-use Study
NCT04228965 COMPLETED PHASE4
Impact of E-cigarette Use on the Body
NCT04972513 ACTIVE_NOT_RECRUITING
Clinical Trial Tobacco Marijuana
NCT02277665 COMPLETED NA